Related Articles
Kisspeptin inhibits cancer growth and metastasis via activation of EIF2AK2
Metastin has potential as a suitable biomarker and novel effective therapy for cancer metastasis (Review)
Antiproliferative effects of kisspeptin‑10 depend on artificial GPR54 (KISS1R) expression levels
Kisspeptin is released from human prostate cancer cell lines but plasma kisspeptin is not elevated in patients with prostate cancer
Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review)